Evaluation of androgen, estrogen (ERa and ERb), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays
A. Latil, I. Biache, D. Vidaud, R. Lidereau, P. Berthon, and O. Cussenot Evaluation of androgen, estrogen (ERa and ERb), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays Cancer Res 61 2001 1919 1926
Estrogen receptor subtypes in ovarian cancer: A clinical correlation
K.K.L. Chan, N. Wei, S.S. Liu, L. Xiao-Yun, A.N. Cheung, and H.Y.S. Ngan Estrogen receptor subtypes in ovarian cancer: a clinical correlation Obstet Gynecol 111 2008 144 151
Primers on molecular pathways: Nuclear receptors in pancreatic cancer. The ligand-independent way
L.P. Nacusi, and J.D. Debes Primers on molecular pathways: nuclear receptors in pancreatic cancer. The ligand-independent way Pancreatology 8 2008 422 424
Radiolabeled estradiol derivatives to predict response to hormonal treatment in breast cancer: A review
C. Van de Wiele, F. De Vos, G. Slegers, S. Van Belle, and R.A. Dierckx Radiolabeled estradiol derivatives to predict response to hormonal treatment in breast cancer: a review Eur J Nucl Med Mol Imaging 27 2000 1421 1433
J.A. Katzenellenbogen Receptor imaging of tumors (non-peptide) M.J. Welch, C.S. Redvanly, Handbook of Radiopharmaceuticals Radiochemistry and Applications 2003 John Wiley & Sons, Ltd. Chichester, UK 715 730
Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography
F. Bénard, and E. Turcotte Imaging in breast cancer: single-photon computed tomography and positron-emission tomography Breast Cancer Res 7 2005 153 162
Estrogen receptor ligands for trageting breast tumours: A brief outlook on radioiodination strategies
M.C. Oliveira, C. Neto, L. Gano, F. Marques, I. Santos, and T. Thiemann Estrogen receptor ligands for trageting breast tumours: a brief outlook on radioiodination strategies Curr Radiopharm 5 2012 124 141 (and references therein)
123I]iodovinyloestradiol and its 11b-methoxy derivative evaluated for their oestrogen receptor binding in human MCF-7 cells and rat uterus, and their distribution in immature rats
123I]iodovinyloestradiol and its 11b-methoxy derivative evaluated for their oestrogen receptor binding in human MCF-7 cells and rat uterus, and their distribution in immature rats Eur J Nucl Med Mol Imaging 23 1996 295 307
Preclinical development of a neutral, estrogen receptor-targeted, tridentate Tc-99m(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers
T.K. Nayak, H.J. Hathaway, C. Ramesh, J.B. Arterburn, D. Dai, and L.A. Sklar Preclinical development of a neutral, estrogen receptor-targeted, tridentate Tc-99m(I)-estradiol-pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers J Nucl Med 49 2008 978 986
Therapy of estrogen receptor-positive micrometastases in the peritoneal cavity with Auger electron-emitting estrogen
E.R. DeSombre, A. Hughes, R.N. Hanson, and T. Kearney Therapy of estrogen receptor-positive micrometastases in the peritoneal cavity with Auger electron-emitting estrogen Acta Oncologica 39 2000 659 666
Estrogen receptor-directed radiotoxicity with auger electrons: Specificity and mean lethal dose
E.R. DeSombre, B. Shafii, R.N. Hanson, P.C. Kuivanen, and A. Hughes Estrogen receptor-directed radiotoxicity with auger electrons: specificity and mean lethal dose Cancer Res 52 1992 5752 5758
11b-Methoxy-, 11b-ethyl, and 17a-ethynyl-substituted 16a- fluoroestradiols: Receptor-based imaging agents with enhanced uptake efficiency and selectivity
M.G. Pomper, H. VanBrocklin, A.M. Thieme, R.D. Thomas, D.O. Kiesewetter, and K.E. Carlson 11b-Methoxy-, 11b-ethyl, and 17a-ethynyl-substituted 16a-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity J Med Chem 33 1990 3143 3155
Preparation of four fluorine-18-labeled estrogens and their selective uptakes in target tissues of immature rats
D.O. Kiesewetter, M.R. Kilbourn, S.W. Landvatter, D.F. Heiman, J.A. Katzenellenbogen, and M.J. Welch Preparation of four fluorine-18-labeled estrogens and their selective uptakes in target tissues of immature rats J Nucl Med 25 1984 1212 1221
18F]Fluoro)estrogens: Systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors
18F]Fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors J Med Chem 36 1993 1619 1629
The synthesis of 7a-methyl-substituted estrogens labeled with fluorine-18: Potential breast tumor imaging agents
H.F. VanBrocklin, A. Liu, M.J. Welch, J.P. O'Neil, and J.A. Katzenellenbogen The synthesis of 7a-methyl-substituted estrogens labeled with fluorine-18: potential breast tumor imaging agents Steroids 59 1994 34 45
Synthesis of 2,16α- and 4,16α-difluoroestradiols and their 11β-methoxy derivatives as potential estrogen receptor-binding radiopharmaceuticals
Y. Seimbille, H. Ali, and J.E. van Lier Synthesis of 2,16α- and 4,16α-difluoroestradiols and their 11β-methoxy derivatives as potential estrogen receptor-binding radiopharmaceuticals J Chem Soc Perk Trans 1 2002 657 663
18F-labeled difluoroestradiols: Preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals
Y. Seimbille, J. Rousseau, and F. Bénard 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals Steroids 67 2002 765-5.
[18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: Impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice
F. Bénard, N. Ahmed, and J.M. Beauregard [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice Eur J Nucl Med Mol Imaging. 35 2008 1473 1479
Synthesis and biodistribution studies of two novel radioiodinated areno-annelated estra-1,3,5(10),16-tetraene-3-ols as promising estrogen receptor radioligands
M.C. Oliveira, M. Videira, A. Almeida, L. Gano, M. Watanabe, and T. Thiemann Synthesis and biodistribution studies of two novel radioiodinated areno-annelated estra-1,3,5(10),16-tetraene-3-ols as promising estrogen receptor radioligands J Labelled Comp Radiopharm 49 2006 559 569
Radioiodinated ligands for the estrogen receptor: Effect of different 7-cyanoalkyl chains on the binding affinity of novel iodovinyl-6- dehydroestradiols
C. Neto, M.C. Oliveira, L. Gano, F. Marques, I. Santos, and G.R. Morais Radioiodinated ligands for the estrogen receptor: effect of different 7-cyanoalkyl chains on the binding affinity of novel iodovinyl-6- dehydroestradiols Appl Radiat Isot 67 2009 301 307
Evaluation of novel radioiodinated C7-substituted 6,7-estradiol derivatives for molecular recognition of ER-positive breast tumours
C. Neto, M.C. Oliveira, L. Gano, F. Marques, I. Santos, and G. Morais Evaluation of novel radioiodinated C7-substituted 6,7-estradiol derivatives for molecular recognition of ER-positive breast tumours Curr Radiopharm 2 2009 83 91
Novel estradiol derivatives with Ru, W, and Co complexes. Influence on hormone-receptor affinity of several organometallic groups at the 17a position
S. Top, H. El Hafa, A. Vessieres, M. Huché, J. Vaissermann, and G. Jaouen Novel estradiol derivatives with Ru, W, and Co complexes. Influence on hormone-receptor affinity of several organometallic groups at the 17a position Chem Eur J 8 2002 5241 5249
Synthesis and radiosynthesis of 17a-[p-(iodophenylethynyl)]estra-3,17b- diols
J. Wang, M. Watanabe, S. Mataka, T. Thiemann, G. Ribeiro Morais, and F. Roleira Synthesis and radiosynthesis of 17a-[p-(iodophenylethynyl)]estra-3,17b- diols Z Naturforsch 58b 2003 799 804
A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography
D.J. Minick, J.H. Frenz, M.A. Patrick, and D.A. Brent A comprehensive method for determining hydrophobicity constants by reversed-phase high-performance liquid chromatography J Med Chem 31 1988 1923 1933
Dehydrohalogenation methodology for synthesizing terminal olefins under mild conditions
M. Bérubé, F. Kamal, J. Roy, and D.A. Poirier Dehydrohalogenation methodology for synthesizing terminal olefins under mild conditions Synthesis 2006 3085 2006 91
Synthesis of 7-w-amidoalkyl-subtituted 6,7-dehydroestra-3,17b-diols
E. Inohae, T. Thiemann, S. Mataka, M.C. Melo e Silva, and L.P. Catela Synthesis of 7-w-amidoalkyl-subtituted 6,7-dehydroestra-3,17b-diols Rep Inst Adv Mater Study 13 1999 31 36
Inhibitors of type 1 17b-hydroxysteroid dehydrogenase with reduced estrogenic activity: Modifications of the positions 3 and 6 of estradiol
M.R. Tremblay, R.P. Boivin, V. Luu-The, and D. Poirier Inhibitors of type 1 17b-hydroxysteroid dehydrogenase with reduced estrogenic activity: modifications of the positions 3 and 6 of estradiol J Enzym Inhib Med Chem 20 2005 153 163
A novel efficient approach to the synthesis of 6-oxo ethinylestradiol and its 3-isopropanesulfonate
G. Weber, J. Schaumann, C. Carl, S. Schwarz, and R. Leisner A novel efficient approach to the synthesis of 6-oxo ethinylestradiol and its 3-isopropanesulfonate J Prakt Chemie 331 1989 223 230
Synthesis and characterization of immunogenic conjugate 17b-oestradiol-6-carboxymethyl-oxime-BSA and 17b-oestradiol-6-carboxymethyl- oxime-tyramine-125I
I. Dorobantu, and E.I. Iancu Synthesis and characterization of immunogenic conjugate 17b-oestradiol-6-carboxymethyl-oxime-BSA and 17b-oestradiol-6-carboxymethyl-oxime-tyramine-125I Revue Romaine de Biochimie 30 1993 15 19
Synthesis and biological evaluation of two new radiolabelled estrogens: [125I](E)-3-methoxy-17a-iodovinylestra-1,3,5(10),6-tetraen-17b-ol and [125I](Z)-3-methoxy-17a-iodovinylestra-1,3,5(10),6-tetraen-17b-ol
M.C. Melo e Silva, L. Patricio, L. Gano, M.L. Sá e Melo, E. Inohae, and S. Mataka Synthesis and biological evaluation of two new radiolabelled estrogens: [125I](E)-3-methoxy-17a-iodovinylestra-1,3,5(10),6- tetraen-17b-ol and [125I](Z)-3-methoxy-17a-iodovinylestra-1,3,5(10),6-tetraen- 17b-ol Appl Radiat Isot 54 2001 227 239
A Novel Route for the Synthesis of 3,4-Dihydro-1H-2-benzopyrans and 1,3,4,5-Tetrahydro-2-benzoxepins
D.G. Talekar, and A.S. Rao A Novel Route for the Synthesis of 3,4-Dihydro-1H-2-benzopyrans and 1,3,4,5-Tetrahydro-2-benzoxepins Synthesis 1983 1983 595 597
Synthesis of (3a,7b,17a)-7-methyl-19-norpregn-5(10)-en-20-yne-3,7,17- triol, a metabolite of ORG OD14, and its 7-epimer
R. Plate, R.C.A.L. van Wuijtswinkel, C.G.J.M. Jans, and M.B. Groen Synthesis of (3a,7b,17a)-7-methyl-19-norpregn-5(10)-en-20-yne-3,7,17-triol, a metabolite of ORG OD14, and its 7-epimer Steroids 65 2000 497 504
Nonpolar and short side chain groups at C-11b of estradiol result in antiestrogens
J. Zhang, D.C. Labaree, and R.B. Hochberg Nonpolar and short side chain groups at C-11b of estradiol result in antiestrogens J Med Chem 48 2005 1428 1447
Structural plasticity in the estrogen receptor-ligand binding domain
K.W. Nettles, J.B. Bruning, G. Gil, E.E. O'Neill, J. Nowack, Y. Guo, Y. Kim, E.R. DeSombre, R. Dilis, R.N. Hanson, A. Joachimiak, and G.L. Greene Structural plasticity in the estrogen receptor-ligand binding domain EMBO Rep 8 2007 563 568